Hypertension. Hypertensive heart disease without (congestive) heart failure
Conditions
Interventions
Intervention 1: The first group were given atenolol 50mg once daily (three weeks). Intervention 2: The second group enalapril 5mg every 12 hours (three weeks). Intervention 3: The third group Hydrochl
Treatment - Drugs
The first group were given atenolol 50mg once daily (three weeks).
The second group enalapril 5mg every 12 hours (three weeks).
The third group Hydrochlorothiazide 50mg once daily (three weeks).
Sponsors
Ardabil University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: All patients with hypertension stage II referred to Buali Hospital in Ardabil; without medications of hypertension; without renal disease (Cr> 1.5); without electrolyte imbalances; no contraindications for use atenolol (asthma, heart block, bradycardia, hypotension); no contraindications for use hydrochlorothiazide (hyperuricemia, initial Hypraldstrvnysm; no contraindications for use enalapril (allergy, renal failure); wishing to participate in the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypertension. Timepoint: Before the experiment, three weeks after intervention. Method of measurement: Mm Hg, using a mercury manometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehzad Babapour
Ardabil University of Medical Sciences
Outcome results
None listed